255 related articles for article (PubMed ID: 29048952)
21. Increasing availability of benzodiazepines among people who inject drugs in a Canadian setting.
Walton G; Dong H; Milloy MJ; DeBeck K; Kerr T; Wood E; Hayashi K
Subst Abus; 2018 Jan; 39(1):69-76. PubMed ID: 28727956
[TBL] [Abstract][Full Text] [Related]
22. Misuse of Prescription and Illicit Drugs in Middle Adulthood in the Context of the Opioid Epidemic.
Faller RW; Erausquin JT; McCoy TP
Subst Use Misuse; 2021; 56(2):333-337. PubMed ID: 33325317
[No Abstract] [Full Text] [Related]
23. An age-based analysis of nonmedical prescription opioid use among people who use illegal drugs in Vancouver, Canada.
Cheng T; Small W; Dong H; Nosova E; Hayashi K; DeBeck K
Subst Abuse Treat Prev Policy; 2018 Nov; 13(1):41. PubMed ID: 30482215
[TBL] [Abstract][Full Text] [Related]
24. Prescription opioid injection and risk of hepatitis C in relation to traditional drugs of misuse in a prospective cohort of street youth.
Hadland SE; DeBeck K; Kerr T; Feng C; Montaner JS; Wood E
BMJ Open; 2014 Jul; 4(7):e005419. PubMed ID: 25052173
[TBL] [Abstract][Full Text] [Related]
25. Discordant reporting of nonmedical opioid use in a nationally representative sample of US high school seniors.
Palamar JJ; Shearston JA; Cleland CM
Am J Drug Alcohol Abuse; 2016 Sep; 42(5):530-538. PubMed ID: 27315427
[TBL] [Abstract][Full Text] [Related]
26. Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting.
Klimas J; Dong H; Fairbairn N; Socías E; Barrios R; Wood E; Kerr T; Montaner J; Milloy MJ
Addict Sci Clin Pract; 2018 Feb; 13(1):3. PubMed ID: 29409539
[TBL] [Abstract][Full Text] [Related]
27. Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs.
Lambdin BH; Bluthenthal RN; Zibbell JE; Wenger L; Simpson K; Kral AH
Int J Drug Policy; 2019 Dec; 74():299-304. PubMed ID: 31733979
[TBL] [Abstract][Full Text] [Related]
28. Withdrawal-associated injury site pain prevalence and correlates among opioid-using people who inject drugs in Vancouver, Canada.
Rieb LM; DeBeck K; Hayashi K; Wood E; Nosova E; Milloy MJ
Drug Alcohol Depend; 2020 Nov; 216():108242. PubMed ID: 32861135
[TBL] [Abstract][Full Text] [Related]
29. Overdose Risk and Acquiring Opioids for Nonmedical Use Exclusively from Physicians in Vancouver, Canada.
Cheng T; Small W; Nosova E; Hogg R; Hayashi K; Kerr T; DeBeck K
Subst Use Misuse; 2020; 55(12):1912-1918. PubMed ID: 32589497
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the population-level effects of oxycodone restrictions on prescription opioid utilization in Ontario.
Rudoler D; Kurdyak P; Gomes T; Huang A; Jones W; Littleford S; Paracha N; Fischer B
Pharmacoepidemiol Drug Saf; 2022 Jul; 31(7):769-778. PubMed ID: 35470515
[TBL] [Abstract][Full Text] [Related]
31. Prescription drug use and misuse in a cohort of people who inject drugs (PWID) in Baltimore.
Anagnostopoulos A; Abraham AG; Genberg BL; Kirk GD; Mehta SH
Addict Behav; 2018 Jun; 81():39-45. PubMed ID: 29425791
[TBL] [Abstract][Full Text] [Related]
32. Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting.
Argento E; Socias ME; Hayashi K; Choi J; Mackay L; Christie D; Milloy MJ; DeBeck K
Int J Drug Policy; 2022 Feb; 100():103518. PubMed ID: 34758431
[TBL] [Abstract][Full Text] [Related]
33. Characteristics Associated with Nonmedical Methadone Use among People Who Inject Drugs in California.
Zhao JK; Kral AH; Wenger LD; Bluthenthal RN
Subst Use Misuse; 2020; 55(3):377-386. PubMed ID: 31608746
[No Abstract] [Full Text] [Related]
34. Patient perspectives of transitioning from prescription opioids to heroin and the role of route of administration.
Monico LB; Mitchell SG
Subst Abuse Treat Prev Policy; 2018 Jan; 13(1):4. PubMed ID: 29378623
[TBL] [Abstract][Full Text] [Related]
35. The Contribution of Prescribed and Illicit Opioids to Fatal Overdoses in Massachusetts, 2013-2015.
Walley AY; Bernson D; Larochelle MR; Green TC; Young L; Land T
Public Health Rep; 2019; 134(6):667-674. PubMed ID: 31577519
[TBL] [Abstract][Full Text] [Related]
36. Changes in substance use in relation to opioid agonist therapy among people who use drugs in a Canadian setting.
Dong H; Hayashi K; Milloy MJ; DeBeck K; Singer J; Wong H; Wood E; Kerr T
Drug Alcohol Depend; 2020 Jul; 212():108005. PubMed ID: 32370932
[TBL] [Abstract][Full Text] [Related]
37. Solution to Detect, Classify, and Report Illicit Online Marketing and Sales of Controlled Substances via Twitter: Using Machine Learning and Web Forensics to Combat Digital Opioid Access.
Mackey T; Kalyanam J; Klugman J; Kuzmenko E; Gupta R
J Med Internet Res; 2018 Apr; 20(4):e10029. PubMed ID: 29613851
[TBL] [Abstract][Full Text] [Related]
38. Incidence of nonmedical use of OxyContin and other prescription opioid pain relievers before and after the introduction of OxyContin with abuse deterrent properties.
Cheng HG; Coplan PM
Postgrad Med; 2018 Aug; 130(6):568-574. PubMed ID: 29978755
[TBL] [Abstract][Full Text] [Related]
39. Consuming illicit opioids during a drug overdose epidemic: Illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market.
Duhart Clarke SE; Kral AH; Zibbell JE
Int J Drug Policy; 2022 Jan; 99():103467. PubMed ID: 34662847
[TBL] [Abstract][Full Text] [Related]
40. Rising role of prescription drugs as a portal to injection drug use and associated mortality in Baltimore, Maryland.
Cepeda JA; Astemborski J; Kirk GD; Celentano DD; Thomas DL; Mehta SH
PLoS One; 2019; 14(3):e0213357. PubMed ID: 30830944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
